drugset / Trial / NCT03248791

Vasopressor Infusion in Cesarean Delivery

NCT03248791

Phase 4 Unknown 120 enrolled Cairo University
RandomizedParallel-groupTriple-blindPrevention

Summary

Comparison will be conducted between continuous variable infusions of both drugs (Phenylephrine and Norepinephrine) with starting doses of 0.75 mcg/Kg/min and 0.1 mcg/Kg/min respectively for prophylaxis against Post-spinal hypotension during cesarean delivery.

Timeline

Start
2017-08-20
Primary completion
2022-03-01
Completion
2022-03-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified 0.1 ug/kg Other
Comparator Phenylephrine Small molecule 0.75 ug/kg Other
Background Bupivacaine Other / unclassified 10 mg Intrathecal

Indications

No indication recorded.